Literature DB >> 7595054

Function of the urokinase receptor (CD87) in neutrophil chemotaxis.

M R Gyetko1, R G Sitrin, J A Fuller, R F Todd, H Petty, T J Standiford.   

Abstract

During recruitment, leukocytes respond to chemotaxins and traverse matrix barriers. Urokinase-type plasminogen activator (uPA), bound to its receptor (uPAR; CD87) facilitates plasmin formation, which promotes matrix proteolysis. Polymorphonuclear leukocytes (PMNs) are critical to the inflammatory response and express both uPA and CD87. To determine whether uPA and CD87 are required for PMN chemotaxis, PMNs were pretreated with an anti-CD87 monoclonal antibody (mAb), a neutralizing anti-uPA mAb, or uPA. PMN chemotaxis was profoundly suppressed by the anti-CD87 mAb but was unaffected by anti-uPA mAb or uPA. The role CD87 plays in chemotaxis may be related to its ability to associate with CR3. CD87/CR3 coupling can be disrupted by specific saccharides. The same saccharides that disrupt CD87/CR3 coupling (NADG, D-mannose, and mannoside) inhibit PMN chemotaxis. We conclude that CD87 plays a crucial role in PMN chemotaxis in vitro that is independent of uPA enzyme activity but may be related to the ability of CD87 to interact with CR3.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7595054     DOI: 10.1002/jlb.58.5.533

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  24 in total

1.  Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells.

Authors:  V Vetvicka; B P Thornton; G D Ross
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Concurrent upregulation of urokinase plasminogen activator receptor and CD11b during tuberculosis and experimental endotoxemia.

Authors:  N P Juffermans; P E Dekkers; A Verbon; P Speelman; S J van Deventer; T van der Poll
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model.

Authors:  M R Gyetko; G H Chen; R A McDonald; R Goodman; G B Huffnagle; C C Wilkinson; J A Fuller; G B Toews
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

4.  The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes.

Authors:  R G Sitrin; R F Todd; E Albrecht; M R Gyetko
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

5.  Global changes in gene expression by human polymorphonuclear leukocytes during receptor-mediated phagocytosis: cell fate is regulated at the level of gene expression.

Authors:  Scott D Kobayashi; Jovanka M Voyich; Cassandra L Buhl; Robert M Stahl; Frank R DeLeo
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

6.  Protein synthesis and urokinase mRNA metabolism.

Authors:  Sreerama Shetty
Journal:  Mol Cell Biochem       Date:  2005-03       Impact factor: 3.396

7.  Analysis of soluble urokinase plasminogen activator receptor in multiple myeloma for predicting prognosis.

Authors:  Jie Shen; Qing Wang; Juan Wang; Guo-Hong Su; Juan Wang; Sheng-Hu Guo; Y A Liu; Zheng Wu; Rong-Feng Liu; Xing Li; Xiao-Jin Guo; Jing Cao; Yue-Hua Zhang; Zhi-Yu Wang
Journal:  Oncol Lett       Date:  2015-08-14       Impact factor: 2.967

8.  Association between urokinase haplotypes and outcome from infection-associated acute lung injury.

Authors:  John Arcaroli; Jeff Sankoff; Nianjun Liu; David B Allison; James Maloney; Edward Abraham
Journal:  Intensive Care Med       Date:  2007-11-10       Impact factor: 17.440

9.  Factor XII and uPAR upregulate neutrophil functions to influence wound healing.

Authors:  Evi X Stavrou; Chao Fang; Kara L Bane; Andy T Long; Clément Naudin; Erdem Kucukal; Agharnan Gandhi; Adina Brett-Morris; Michele M Mumaw; Sudeh Izadmehr; Alona Merkulova; Cindy C Reynolds; Omar Alhalabi; Lalitha Nayak; Wen-Mei Yu; Cheng-Kui Qu; Howard J Meyerson; George R Dubyak; Umut A Gurkan; Marvin T Nieman; Anirban Sen Gupta; Thomas Renné; Alvin H Schmaier
Journal:  J Clin Invest       Date:  2018-01-29       Impact factor: 14.808

10.  The urokinase plasminogen activator receptor promotes efferocytosis of apoptotic cells.

Authors:  Veera D'mello; Sukhwinder Singh; Yi Wu; Raymond B Birge
Journal:  J Biol Chem       Date:  2009-04-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.